Your request to link to rcsb for Retinoic acid receptor gamma

• 1DSZ: structure of the rxr/rar dna-binding domain heterodimer in complex with the retinoic acid response element dr1 (10.1093/EMBOJ/19.5.1045 )
• 1EXA: enantiomer discrimination illustrated by crystal structures of the human retinoic acid receptor hrargamma ligand binding domain: the complex with the active r-enantiomer bms270394. (10.1073/PNAS.97.12.6322 )
• 1EXX: enantiomer discrimination illustrated by crystal structures of the human retinoic acid receptor hrargamma ligand binding domain: the complex with the inactive s-enantiomer bms270395. (10.1073/PNAS.97.12.6322 )
• 1FCX: isotype selectivity of the human retinoic acid nuclear receptor hrar: the complex with the rargamma-selective retinoid bms184394 (10.1006/JMBI.2000.4032 )
• 1FCY: isotype selectivity of the human retinoic acid nuclear receptor hrar: the complex with the rarbeta/gamma-selective retinoid cd564 (10.1006/JMBI.2000.4032 )
• 1FCZ: isotype selectivity of the human retinoic acid nuclear receptor hrar: the complex with the panagonist retinoid bms181156 (10.1006/JMBI.2000.4032 )
• 1FD0: isotype selectivity of the human retinoic acid nuclear receptor hrar: the complex with the rargamma-selective retinoid sr11254 (10.1016/S0969-2126(02)00828-6 )
• 1HRA: the solution structure of the human retinoic acid receptor- beta dna-binding domain (10.1007/BF00242472 )
• 1XAP: structure of the ligand binding domain of the retinoic acid receptor beta (10.1038/SJ.EMBOR.7400235 )
• 2LBD: ligand-binding domain of the human retinoic acid receptor gamma bound to all-trans retinoic acid (10.1038/378681A0 )
• 3LBD: ligand-binding domain of the human retinoic acid receptor gamma bound to 9-cis retinoic acid (10.1038/NSB0398-199 )
• 4DM6: crystal structure of rarb lbd homodimer in complex with ttnpb (10.1073/PNAS.1118192109 )
• 4DM8: crystal structure of rarb lbd in complex with 9cis retinoic acid (10.1073/PNAS.1118192109 )
• 4JYG: crystal structure of rarbeta lbd in complex with agonist bms411 [4- {[(5,5-dimethyl-8-phenyl-5,6-dihydronaphthalen-2-yl) carbonyl]amino}benzoic acid] (10.1371/JOURNAL.PONE.0123195 )
• 4JYH: crystal structure of rarbeta lbd in complex with selective agonist bms948 [4-{[(8-phenylnaphthalen-2-yl)carbonyl]amino}benzoic acid] (10.1371/JOURNAL.PONE.0123195 )
• 4JYI: crystal structure of rarbeta lbd in complex with selective partial agonist bms641 [3-chloro-4-[(e)-2-(5,5-dimethyl-8-phenyl-5,6- dihydronaphthalen-2-yl)ethenyl]benzoic acid] (10.1371/JOURNAL.PONE.0123195 )
• 4LBD: ligand-binding domain of the human retinoic acid receptor gamma bound to the synthetic agonist bms961 (10.1038/NSB0398-199 )
• 5M24: rarg mutant-s371e (10.1371/JOURNAL.PONE.0171043 )
• 5UAN: crystal structure of multi-domain rar-beta-rxr-alpha heterodimer on dna (10.1038/S41467-017-00981-Y )
• 6FX0: structure-based design of trifarotene (cd5789), a potent and selective rar gamma agonist for the treatment of acne (10.1016/J.BMCL.2018.04.036 )
• 6SSQ: crystal structure of rarbeta lbd in complex with lg 100754 (10.3390/CELLS8111392 )
• 6XWG: crystal structure of the human rxr/rar dna-binding domain heterodimer bound to the human rarb2 dr5 response element (10.1093/NAR/GKAA697 )